SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Paulus A)
 

Sökning: WFRF:(Paulus A) > Searching for Atria...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00008380naa a2200913 4500
001oai:lup.lub.lu.se:6d07505f-d423-4858-8033-b3fffd0b305f
003SwePub
008191204s2019 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:142492508
024a https://lup.lub.lu.se/record/6d07505f-d423-4858-8033-b3fffd0b305f2 URI
024a https://doi.org/10.1161/CIRCULATIONAHA.119.0402672 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1424925082 URI
040 a (SwePub)lud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Schnabel, Renate B.u University Medical Center Hamburg-Eppendorf,German Centre for Cardiovascular Research4 aut
2451 0a Searching for Atrial Fibrillation Poststroke : A White Paper of the AF-SCREEN International Collaboration
264 1c 2019
300 a 17 s.
520 a Cardiac thromboembolism attributed to atrial fibrillation (AF) is responsible for up to one-third of ischemic strokes. Stroke may be the first manifestation of previously undetected AF. Given the efficacy of oral anticoagulants in preventing AF-related ischemic strokes, strategies of searching for AF after a stroke using ECG monitoring followed by oral anticoagulation (OAC) treatment have been proposed to prevent recurrent cardioembolic strokes. This white paper by experts from the AF-SCREEN International Collaboration summarizes existing evidence and knowledge gaps on searching for AF after a stroke by using ECG monitoring. New AF can be detected by routine plus intensive ECG monitoring in approximately one-quarter of patients with ischemic stroke. It may be causal, a bystander, or neurogenically induced by the stroke. AF after a stroke is a risk factor for thromboembolism and a strong marker for atrial myopathy. After acute ischemic stroke, patients should undergo 72 hours of electrocardiographic monitoring to detect AF. The diagnosis requires an ECG of sufficient quality for confirmation by a health professional with ECG rhythm expertise. AF detection rate is a function of monitoring duration and quality of analysis, AF episode definition, interval from stroke to monitoring commencement, and patient characteristics including old age, certain ECG alterations, and stroke type. Markers of atrial myopathy (eg, imaging, atrial ectopy, natriuretic peptides) may increase AF yield from monitoring and could be used to guide patient selection for more intensive/prolonged poststroke ECG monitoring. Atrial myopathy without detected AF is not currently sufficient to initiate OAC. The concept of embolic stroke of unknown source is not proven to identify patients who have had a stroke benefitting from empiric OAC treatment. However, some embolic stroke of unknown source subgroups (eg, advanced age, atrial enlargement) might benefit more from non-vitamin K-dependent OAC therapy than aspirin. Fulfilling embolic stroke of unknown source criteria is an indication neither for empiric non-vitamin K-dependent OAC treatment nor for withholding prolonged ECG monitoring for AF. Clinically diagnosed AF after a stroke or a transient ischemic attack is associated with significantly increased risk of recurrent stroke or systemic embolism, in particular, with additional stroke risk factors, and requires OAC rather than antiplatelet therapy. The minimum subclinical AF duration required on ECG monitoring poststroke/transient ischemic attack to recommend OAC therapy is debated.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a anticoagulants
653 a atrial fibrillation
653 a cardiomyopathies
653 a electrocardiography
653 a stroke
700a Haeusler, Karl Georgu University Hospital of Wϋrzburg4 aut
700a Healey, Jeffrey S.u McMaster University4 aut
700a Freedman, Benu University of Sydney4 aut
700a Boriani, Giuseppeu University of Modena and Reggio Emilia4 aut
700a Brachmann, Johannesu Klinikum Coburg4 aut
700a Brandes, Axelu Odense University Hospital4 aut
700a Bustamante, Alejandrou Vall d'Hebron University Hospital4 aut
700a Casadei, Barbarau University of Oxford4 aut
700a Crijns, Harry J.G.M.u Maastricht University Medical Centre4 aut
700a Doehner, Wolframu Charité - University Medicine Berlin,German Centre for Cardiovascular Research4 aut
700a Engström, Gunnaru Lund University,Lunds universitet,Kardiovaskulär forskning - epidemiologi,Forskargrupper vid Lunds universitet,Cardiovascular Research - Epidemiology,Lund University Research Groups4 aut0 (Swepub:lu)smi-gen
700a Fauchier, Laurentu University Hospital of Tours,University Of Tours4 aut
700a Friberg, Leifu Karolinska Institute4 aut
700a Gladstone, David J.u University of Toronto,Sunnybrook Health Sciences Centre4 aut
700a Glotzer, Taya V.u Hackensack University Medical Center4 aut
700a Goto, Shinyau Tokai University4 aut
700a Hankey, Graeme J.u Sir Charles Gairdner Hospital,University of Western Australia, Perth4 aut
700a Harbison, Joseph A.u Trinity College Dublin4 aut
700a Hobbs, F. D.Richardu University of Oxford4 aut
700a Johnson, Linda S.B.u Lund University,Lunds universitet,Kardiovaskulär forskning - epidemiologi,Forskargrupper vid Lunds universitet,Cardiovascular Research - Epidemiology,Lund University Research Groups4 aut0 (Swepub:lu)med-laj
700a Kamel, Hoomanu Cornell University4 aut
700a Kirchhof, Paulusu University of Birmingham,University Hospitals Birmingham4 aut
700a Korompoki, Eleniu Imperial College London4 aut
700a Krieger, Derk W.u Mohammed Bin Rashid University of Medicine and Health Sciences,Mediclinic City Hospital, Dubai4 aut
700a Lip, Gregory Y.H.u Liverpool Heart and Chest Hospital,University of Liverpool4 aut
700a Løchen, Maja Lisau University Hospital of North Norway4 aut
700a Mairesse, Georges H.u Cliniques du Sud Luxembourg4 aut
700a Montaner, Joanu Vall d'Hebron University Hospital4 aut
700a Neubeck, Lisu Edinburgh Napier University4 aut
700a Ntaios, Georgeu University of Thessaly4 aut
700a Piccini, Jonathan P.u Duke Clinical Research Institute (DCRI),Duke University Medical Center4 aut
700a Potpara, Tatjana S.u University of Belgrade4 aut
700a Quinn, Terence J.u University of Glasgow4 aut
700a Reiffel, James A.u Columbia University4 aut
700a Ribeiro, Antonio Luiz Pinhou Federal University of Minas Gerais,Hospital das Clínicas da Universidade Federal de Minas Gerais4 aut
700a Rienstra, Michielu University Medical Center Groningen,University of Groningen4 aut
700a Rosenqvist, Mårtenu Karolinska Institute4 aut
700a Sakis, Themistoclakisu Venice-Mestre Hospital (Ospedale dell'Angelo)4 aut
700a Sinner, Moritz F.u University Hospital Munich,German Centre for Cardiovascular Research,Ludwig-Maximilian University of Munich4 aut
700a Svendsen, Jesper Hastrupu University of Copenhagen,Copenhagen University Hospital4 aut
700a Van Gelder, Isabelle C.u University of Groningen,University Medical Center Groningen4 aut
700a Wachter, Rolfu German Centre for Cardiovascular Research,University Hospital Leipzig,University Medical Center Göttingen4 aut
700a Wijeratne, Tissau Sunshine Hospital, St Albans,University of Melbourne4 aut
700a Yan, Bernardu Royal Melbourne Hospital4 aut
710a University Medical Center Hamburg-Eppendorfb German Centre for Cardiovascular Research4 org
773t Circulationg 140:22, s. 1834-1850q 140:22<1834-1850x 1524-4539
856u http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040267y FULLTEXT
8564 8u https://lup.lub.lu.se/record/6d07505f-d423-4858-8033-b3fffd0b305f
8564 8u https://doi.org/10.1161/CIRCULATIONAHA.119.040267
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:142492508

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy